AI Visibility Scorecard
Novoeight® (Antihemophilic Factor [Recombinant])
novoeight.com · Healthcare
Borderline visible. AI bots can crawl Novoeight® (Antihemophilic Factor [Recombinant]), but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
AI engines read this profile 6 times
Meta AI · Claude · ShapBot
#46,722 of 925,096 in Healthcare for AI visibility
<1
4
AEO Visibility
iBorderline · 4.2/10
5
Muse Index Score
iAI agent readiness
Basic · 5/100
0
AI Adoption
iNone detected · 0/100
About Novoeight® (Antihemophilic Factor [Recombinant])
from our crawl and measurement
Novoeight® (Antihemophilic Factor [Recombinant]) is a business whose own site puts it this way: "If you are looking for a FVIII product that's ready to go, controls bleeds, and has an established safety profile, Novoeight® offers all 3." When AI engines look at it, they find little to work with. It scores 4.2 out of 10.
On its own pages the site does well on a clear heading structure, a clearly stated business identity and sitemaps and entity links AI can follow. It is passable on a few credibility markers and basic crawler access. What holds it back is structured data describing the business.
Off the page, other sites link to it. There is some, but not much, sign that the domain is only lightly established. Beyond that, AI engines do not yet recognise it as a distinct business, there is no press coverage to draw on, nobody is discussing it where AI engines look and it does not come up on Reddit. None of that can be fixed on the page: it has to be earned.
AI crawlers have visited once in our tracking, including ClaudeBot (Anthropic).
The 6 signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Good
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Fair
Experience, Expertise, Authority, Trust markers.
Technical AEO
Fair
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Good
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
Strong
Inbound links from other sites.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 4.2/10, Novoeight® (Antihemophilic Factor [Recombinant]) is crawlable but under-signaled - fixable, and the signals above are where to start.
Frequently Asked Questions
How can we help?
Novo Nordisk Rare Blood Community Liaisons (RBCLs) are here to answer your questions about Novoeight® and connect you with resources to help you manage your bleeding disorder. Connect with your RBCL
How does it work?
Novoeight® delivers reliable bleed control. It was proven effective in one of the largest clinical trial programs to date. Learn About Bleed Control David lives with hemophilia A. David lives with hemophilia A.
Are you on Facebook?
If you’re interested in the latest updates about Novoeight® and our team, “like” our page. Follow Us
What is Novoeight®?
Novoeight® (antihemophilic factor, recombinant) is an injectable medicine used to control and prevent bleeding in people with hemophilia A.
What is Esperoct®?
Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei] is an injectable medicine to treat and prevent or reduce the number of bleeding episodes in people with hemophilia A.
Is this your brand?
The exact fixes for Novoeight® (Antihemophilic Factor [Recombinant])
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Already have an account? Sign in
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Novoeight® (Antihemophilic Factor [Recombinant]).
Source & Attribution
Scored by Engagemii on August 2, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/novoeight
Cite this score: Engagemii (2026). "AEO Score for Novoeight® (Antihemophilic Factor [Recombinant])." Retrieved from https://engagemii.com/aeo/brands/novoeight
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform